SAN DIEGO (AP) _ Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $5.9 million in its first quarter.
On a per-share basis, the San Diego-based company said it had a loss of 25 cents.
The biopharmaceutical company posted revenue of $6 million in the period.
In the final minutes of trading on Thursday, the company's shares hit 66 cents. A year ago, they were trading at $1.45.